DEFA14AGTBPCIK 0000109657

GT Biopharma, Inc.

Name: SEC EDGAR filing 0001641172-25-014722
Creator: GT Biopharma, Inc.
License: https://www.usa.gov/government-works

DEFA14A (DEFA14A) filed June 11, 2025.

Read the filing on SEC.gov All documents in this filing

New to the DEFA14A? What it is and how to read one

Filing facts

Accession number: 0001641172-25-014722
Filer: GT Biopharma, Inc.
Ticker: GTBP
CIK: 0000109657
Form type: DEFA14A
Filed at: June 11, 2025
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 1.1 MB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from GT Biopharma, Inc.

See all 45 filings from GT Biopharma, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/109657/000164117225014722/0001641172-25-014722-index.htm ↗

Filer's full EDGAR submission history

EDGAR · GT Biopharma, Inc. (0000109657) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.